04:43 PM EDT, 08/20/2025 (MT Newswires) -- Eben Tessari, COO, on August 18, 2025, sold 16,200 shares in Kiniksa Pharmaceuticals International ( KNSA ) for $547,141. Following the Form 4 filing with the SEC, Tessari has control over a total of 40,215 Class A ordinary shares of the company, with 40,215 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1730430/000141588925022460/xslF345X05/form4-08202025_080850.xml